These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4504773)

  • 1. Further evaluation of the antitumor activity of homofolate and its reduced derivatives against methotrexate-insensitive tumors.
    Mishra LC; Mead JA
    Chemotherapy; 1972; 17(4):283-92. PubMed ID: 4504773
    [No Abstract]   [Full Text] [Related]  

  • 2. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the antitumor activity of rifamycin SV.
    Adamson RH
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):61-5. PubMed ID: 5093193
    [No Abstract]   [Full Text] [Related]  

  • 4. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic aspects of homofolate derivatives in relation to amethopterin-resistant murine leukemia.
    Mead JA; Goldin A; Kisliuk RL; Friedkin M; Plante L; Crawford EJ; Kwok G
    Cancer Res; 1966 Nov; 26(11):2374-9. PubMed ID: 4959533
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental studies on the antitumor effect of ethidium bromide and related substances.
    Nishiwaki H; Miura M; Imai K; Ono R; Kawashima K
    Cancer Res; 1974 Oct; 34(10):2699-703. PubMed ID: 4413384
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Vermeulen NM; Ashton WT; Ryan AJ
    J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z; Lukowicz J; Konopa J
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of sparsomycin analogs as potential antitumor agents.
    Dubois RJ; Lin CC; Michel BL
    J Pharm Sci; 1975 May; 64(5):825-9. PubMed ID: 1151655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 12. New approaches to chemotherapy with folate antagonists: use of leucovorin "rescue" and enzymic folate depletion.
    Bertino JR; Levitt M; McCullough JL; Chabner B
    Ann N Y Acad Sci; 1971 Nov; 186():486-95. PubMed ID: 4943812
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity relationships in antitumor aniline mustards.
    Panthananickal A; Hansch C; Leo A
    J Med Chem; 1978 Jan; 21(1):16-26. PubMed ID: 619146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
    Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
    Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic agents. 36. Acetylenic carrier groups.
    Pettit GR; Saldana EI
    J Med Chem; 1974 Aug; 17(8):896-8. PubMed ID: 4845382
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential anticancer agents. 17. Analogues of methotrexate with a tripeptide side chain.
    Suster DC; Tărnăuceanu E; Botez G; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1978 Nov; 21(11):1165-7. PubMed ID: 722723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tomizine--a new inhibitor of folate metabolism enzymes possessing an antitumor activity].
    Sokolova AS; Riabokon' NA; Ershova IuA; Andreeva NA; Nemeriuk MP
    Vopr Onkol; 1975; 21(11):45-50. PubMed ID: 174306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS; Schmid FA; Hutchison DJ; Stock CC
    Cancer Chemother Rep; 1973 Feb; 57(1):21-7. PubMed ID: 4704098
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential anticancer agents. 16. Methotrexate analogues with a modified peptide side chain.
    Suster DC; Tărnăuceanu E; Ionescu D; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1978 Nov; 21(11):1162-5. PubMed ID: 722722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of 4-(p-(bis(2-chloroethyl)amino)phenyl)butyramides as potential antitumor agents. I.
    Billman JH; Roehrig GR
    J Pharm Sci; 1974 Sep; 63(9):1487-9. PubMed ID: 4427280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.